Process for preparing cadaverine adipate
By culturing L-lysine-producing microorganisms with diammonium adipate and enzymatically converting lysine adipate to cadaverine adipate, the method addresses the inefficiencies in cadaverine adipate production, achieving high-purity cadaverine adipate with improved yield and reduced environmental impact.
Patent Information
- Application Number
- PCT/KR2024/006740
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-18
- Filing Date
- 2024-05-17
- Publication Date
- 2024-11-21
AI Technical Summary
The existing process for producing cadaverine adipate faces inefficiencies due to the precipitation of adipine salt crystals during crystallization, requiring additional steps for removal and leading to environmental pollution and reduced process efficiency, especially with the use of chemical solvents.
The method involves culturing L-lysine-producing microorganisms in a medium containing diammonium adipate, enzymatically converting lysine adipate to cadaverine adipate, thereby eliminating the need for separate salt removal processes and preventing adipine salt precipitation, allowing for high-purity cadaverine adipate production.
This approach simplifies the production process, enhances yield, and achieves high-purity cadaverine adipate without the need for conventional ion resin exchange or distillation, reducing environmental impact and improving process efficiency.
Smart Images

Figure KR2024006740_21112024_PF_FP_ABST
Abstract
Description
Cadaverine adipate manufacturing process
[0001] The present application relates to a technology for producing high purity cadaverine adipate using a microbial fermentation and purification process.
[0002] Cadaverine is a toxic, foul-smelling diamine compound produced by the decomposition of animal tissue. Furthermore, cadaverine adipate is a polymerization precursor for bio-polyamides, a type of engineering plastic widely used in automotive, electrical, and electronic components.
[0003] The process for preparing cadaverine adipate generally includes the following steps:
[0004] Synthesis of Cadaverine: Cadaverine synthesis involves the fermentation of suitable microbial strains capable of producing lysine decarboxylase, an enzyme that catalyzes the decarboxylation of lysine to cadaverine.
[0005] Preparation of adipic acid: Adipic acid, another monomer required for the production of cadaverine adipate, can be synthesized by various methods, such as oxidation of cyclohexene or cyclohexanol using nitric acid or air.
[0006] Formation of cadaverine adipate: The formation of cadaverine adipate involves the reaction between cadaverine and adipic acid in the presence of a suitable catalyst, such as sulfuric or phosphoric acid. The reaction typically involves mixing the two monomers at a suitable temperature and stirring for a specified period of time to ensure complete reaction.
[0007] Purification of cadaverine adipate: Once the reaction is complete, the raw material, cadaverine adipate, is purified using various separation and purification techniques such as solvent extraction, chromatography, and crystallization.
[0008] According to the prior art, because adipate has low solubility, there was a problem that adipate precipitated into crystals together with cadaverine adipate during the crystallization process in the above-described process. Therefore, to produce high-purity cadaverine adipate, adipate had to be removed before crystallization, and there were problems such as the burden of cost due to performing an additional process to remove adipate, decreased process efficiency, and environmental pollution due to the use of chemical solvents.
[0009] The problem to be solved by the present application is to provide a method for producing cadaverine adipate.
[0010] The present application provides a method for producing high-purity cadaverine adipate without the conventional ion resin exchange, decarboxylation process, or distillation process by culturing a lysine-producing microorganism by adding diammonium adipate to it.
[0011] According to one aspect of the present application, by culturing an L-lysine producing microorganism in a medium containing diammonium adipate to obtain lysine adipate, and enzymatically converting the lysine adipate into cadaverine adipate, a separate process for removing the adipate is not required, thereby simplifying the process, and at the same time, a high-purity cadaverine adipate can be produced in a high yield because adipic acid crystals are not precipitated together as a byproduct.
[0012] Figure 1 is a flowchart showing a process for manufacturing cadaverine adipate according to the present application.
[0013] Figure 2 is a flowchart showing a process for manufacturing cadaverine adipate according to one embodiment of the present application.
[0014] Figure 3 is a graph showing the results of converting lysine adipate into cadaverine adipate using a strain expressing lysine decarboxylase.
[0015] This is explained in detail as follows. Meanwhile, each description and embodiment disclosed in this application can also be applied to each other description and embodiment. In other words, all combinations of the various elements disclosed in this application fall within the scope of this application. Furthermore, the scope of this application is not limited by the specific descriptions described below.
[0016]
[0017] One aspect of the present application provides a method for producing cadaverine adipate, comprising a first step of culturing an L-lysine producing microorganism in a medium to which adipic acid is added in the form of diammonium adipate to obtain lysine adipate, and a second step of converting the lysine adipate into cadaverine adipate.
[0018]
[0019] The term "cadaverine (CAD)" in this application refers to a foul-smelling, toxic diamine compound with the chemical formula NH2(CH2)5NH2. Cadaverine may also be referred to as 1,5-pentanediamine or pentamethylenediamine. It should be understood that cadaverine in this application includes the form of cadaverine adipate.
[0020] The term "cadaverine adipate" in this application refers to a substance manufactured by reacting cadaverine in the form of the above diamine with adipic acid, which is a dicarboxylic acid component, and has high industrial utility as a precursor for manufacturing polyamide resin.
[0021]
[0022] Figures 1 and 2 are flowcharts showing a process for manufacturing cadaverine adipate according to one embodiment of the present application.
[0023]
[0024] In this application, the term "L-lysine producing microorganism" includes both wild type microorganisms and microorganisms that have undergone natural or artificial genetic modification, and may be a microorganism that includes genetic modification for the production of L-lysine, as a microorganism whose specific mechanism has been weakened or strengthened due to causes such as insertion of an external gene or enhancement or inactivation of the activity of an endogenous gene.
[0025] In one example, the microorganism producing L-lysine of the present application may be, but is not limited to, a microorganism that naturally has L-lysine production ability, a microorganism that has L-lysine production ability conferred on a microorganism that does not have L-lysine production ability, or a microorganism that has significantly low L-lysine production ability enhanced with L-lysine production ability. Specifically, the microorganism producing L-lysine or the microorganism having L-lysine production ability of the present application may be a microorganism in which some of the genes in the L-lysine biosynthesis pathway are enhanced or weakened, or some of the genes in the L-lysine degradation pathway are enhanced or weakened. "Enhanced" or "increased" L-lysine production ability means that the L-lysine production ability is improved compared to a parent strain or an unmodified microorganism.
[0026] As a specific example, the microorganism may be a microorganism of the genus Corynebacterium or a microorganism of the genus Escherichia. The microorganism of the genus Corynebacterium may include all microorganisms belonging to the genus Corynebacterium. Specifically, Corynebacterium glutamicum, Corynebacterium crudilactis, Corynebacterium deserti, Corynebacterium efficiens, Corynebacterium callunae, Corynebacterium stationis, Corynebacterium singulare, Corynebacterium halotolerans, Corynebacterium striatum, Corynebacterium ammoniagenes, Corynebacterium pollutisoli pollutisoli), Corynebacterium imitans, Corynebacterium testudinoris or Corynebacterium flavescens, and more specifically, but not limited to, Corynebacterium glutamicum. Microorganisms of the genus Escheria may include all microorganisms belonging to the genus Escheria.Specifically, it may be Escherichia coli, Escherichia albertii, Escherichia blattae, Escherichia fergusonii, Escherichia hermannii or Escherichia vulneris, and more specifically, the strain of the genus Escherichia may be Escherichia coli, but is not limited thereto.
[0027] The above L-lysine-producing microorganism can be cultivated using suitable media and culture conditions known in the art. This cultivation process can be easily adjusted and used by those skilled in the art depending on the selected microorganism. Specifically, the cultivation may be batch, continuous, or fed-batch, but is not limited thereto.
[0028] In this application, the term "medium" refers to a material containing nutrients necessary for culturing the microorganism as a main component, and supplies nutrients and growth factors, including water, which is essential for survival and growth. Specifically, the medium used for culturing the L-lysine-producing microorganism of the present application may be any medium used for culturing general microorganisms without particular limitation, except that it contains diammonium adipate as part or all of the nitrogen source. The microorganism of the present application can be cultured under aerobic conditions while controlling temperature, pH, etc. in a general medium containing a nitrogen source including diammonium adipate, an appropriate carbon source, phosphorus, inorganic compounds, amino acids, and / or vitamins.
[0029]
[0030] The term "adipic acid" in this application refers to a dicarboxylic acid having six carbon atoms and having the chemical formula (CH2)4(COOH)2, and generally exists as white crystals or crystalline powder. The adipic acid is also called adipic acid, hexanedioic acid, etc., and is a compound with high industrial utility, mostly as a precursor for producing nylon.
[0031]
[0032] The first step of the method for producing cadaverine dicarboxylate of the present application is a step of culturing an L-lysine-producing microorganism in a medium to which adipic acid is added in the form of diammonium adipate to obtain lysine adipate. This can be achieved through a fermentation process of the lysine-producing microorganism.
[0033]
[0034] In the first step, the adipic acid can be supplied to the medium in the form of diammonium adipate, and accordingly, it should be understood that the adipic acid in the present application includes the form of diammonium adipate.
[0035] The term "diammonium adipate" in this application refers to a form of adipic acid in which two hydrogen atoms are replaced by ammonium, and is used as the main nitrogen source of the medium. The diammonium adipate may be prepared by gently mixing adipic acid with ammonia water to have a neutral pH, and then concentrated to form crystals or in liquid form, but is not limited thereto.
[0036]
[0037] The manufacturing method of the present application can manufacture cadaverine adipate with high purity while simplifying the process by adding 56 mol% or more of the adipic acid supplied throughout the process in the form of diammonium adipate to the medium in the first step, and can reduce the side effect of adipate being precipitated together with cadaverine adipate.
[0038] Specifically, the diammonium adipate of the first step can be included in the medium at a high ratio, specifically 81 mol% or more, relative to the adipic acid supplied throughout the entire process of the manufacturing method of the present application.
[0039] More specifically, the diammonium adipate of the first step may be included in an amount of 56 mol% or more, 66 mol% or more, 74 mol% or more, 81 mol% or more, 82 mol% or more, 83 mol% or more, 84 mol% or more, 85 mol% or more, 86 mol% or more, 87 mol% or more, 88 mol% or more, 89 mol% or more, 90 mol% or more, 91 mol% or more, 92 mol% or more, 93 mol% or more, 94 mol% or more, 95 mol% or more, 96 mol% or more, 97 mol% or more, 98 mol% or more, 99 mol% or more, or 100 mol% of the adipic acid supplied in the entire process of the manufacturing method of the present application.
[0040] The manufacturing method of the present application can provide an advantage in that, unlike conventional processes that add ammonium sulfate, etc., by including a large amount of diammonium adipate in the medium, high-purity cadaverine adipate can be manufactured without performing a separate adipate removal step such as ion resin exchange, decarboxylation process, or distillation process. In addition, by using diammonium adipate, it is possible to easily adjust the molar ratio of adipic acid added throughout the entire process / cadaverine in the process solution after the second step.
[0041]
[0042] Specifically, the diammonium adipate of the first step may be included so that the molar ratio (diammonium adipate / lysine) with respect to the lysine to be produced is 0.55 to 1. More specifically, the diammonium adipate of the first step may be included so that the molar ratio (diammonium adipate / lysine) with respect to the lysine to be produced is 0.65 to 0.98, 0.73 to 0.98, or 0.85 to 0.98, and more specifically 0.88 to 0.96. At this time, it should be understood that the amount of lysine to be produced refers to the total amount including all forms of lysine adipate.
[0043] For example, the diammonium adipate of the first step may be included in a molar ratio (diammonium adipate / lysine) with the lysine to be produced in a range consisting of a lower limit selected from 0.55, 0.60, 0.65, 0.7, 0.85, 0.86, 0.87, 0.88, 0.89, 0.9, 0.91, and 0.92 and / or an upper limit selected from 1, 0.99, 0.98, 0.97, 0.96, 0.95, 0.94, 0.93, and 0.92.
[0044]
[0045] Specifically, the diammonium adipate of the first step may be included in an amount of 70 g / L to 140 g / L based on the fermented broth of the L-lysine-producing microorganism. More specifically, the diammonium adipate of the first step may be included in an amount of 80 g / L to 130 g / L, 90 g / L to 130 g / L, 105 g / L to 130 g / L, or 105 g / L to 120 g / L based on the fermented broth of the L-lysine-producing microorganism. By adding diammonium adipate at the above concentration, ammonium ions act as a nitrogen source during fermentation, and adipic acid and lysine form a salt, which may be included in a dissolved state in the fermented broth.
[0046]
[0047] Lysine adipate can be produced through fermentation of L-lysine-producing microorganisms in a medium containing diammonium adipate. Lysine adipate can be introduced into subsequent processes in the form of a fermentation broth containing the cells, a fermentation broth with the cells removed, or after concentration or purification.
[0048]
[0049] The concentration of lysine in the fermentation liquid in which the first-stage lysine-producing microorganism of the present application is cultured is not limited, but may be 90 g / L to 300 g / L, 95 g / L to 250 g / L, 97 g / L to 160 g / L, or 97 g / L to 100 g / L based on the fermentation liquid of the L-lysine-producing microorganism.
[0050]
[0051] The carbon source of the above medium may include carbohydrates such as glucose, fructose, sucrose, maltose, and their isomers; sugar alcohols such as mannitol and sorbitol; organic acids such as pyruvic acid, lactic acid, and citric acid; and amino acids such as glutamic acid, methionine, and lysine. In addition, natural organic nutrients such as starch hydrolysate, molasses, blackstrap molasses, rice winter, cassava, sugarcane bagasse, and corn steep liquor may be used, and specifically, carbohydrates such as glucose and sterilized pretreated molasses (i.e., molasses converted to reducing sugar) may be used, and other appropriate carbon sources may be used in various ways without limitation. These carbon sources may be used alone or in combination of two or more, but are not limited thereto.
[0052] As a specific example, the carbon source that may be included in the culture medium of the present application may include glucose, maltose, or maltose isomers. More specifically, the carbon source may include at least one selected from among glucose, maltose, and maltose isomers (isomaltose), or a combination of two or more thereof, but is not limited thereto.
[0053] The above-mentioned badge may include potassium phosphate monobasic, potassium phosphate dibasic, or their corresponding sodium-containing salts. Inorganic compounds may include sodium chloride, calcium chloride, iron chloride, magnesium sulfate, iron sulfate, manganese sulfate, calcium carbonate, and the like.
[0054] Additionally, the culture medium may contain metal salts, such as magnesium sulfate or iron sulfate, necessary for growth. Finally, in addition to the above substances, essential growth substances, such as amino acids and vitamins, may be used. Appropriate precursors may also be used in the culture medium. The above-mentioned raw materials may be added to the culture in an appropriate manner during the cultivation process, for example, batchwise or continuously, but are not limited thereto.
[0055] The nitrogen source of the above medium may include diammonium adipate. A typical medium for microbial culture may include an inorganic nitrogen source such as ammonia, ammonium sulfate, ammonium chloride, ammonium acetate, ammonium phosphate, ammonium carbonate, ammonium nitrate, etc. as a nitrogen source; an organic nitrogen source such as amino acids such as glutamic acid, methionine, glutamine, etc., peptone, NZ-amine, meat extract, yeast extract, malt extract, corn steep liquor, casein hydrolysate, fish or its decomposition product, defatted soybean cake or its decomposition product, etc. However, in one embodiment of the present application, diammonium adipate may be included as the sole nitrogen source or as an additional nitrogen source.
[0056]
[0057] After the first step of producing lysine adipate by culturing an L-lysine producing microorganism in a medium containing diammonium adipate, a second step of converting lysine adipate into cadaverine adipate can be performed.
[0058]
[0059] The second step refers to the step of converting lysine adipate into the target product, cadaverine adipate.
[0060]
[0061] In one specific embodiment, the second step may further comprise adding adipic acid to the process liquid. The process liquid may be the fermentation process liquid obtained in the first step.
[0062] The adipic acid added in the second step may not be added or may be added in a trace amount of 0.6 mol / L or less, 0.35 mol / L or less, 0.18 mol / L or less, 0.1 mol / L or less, 0.08 mol / L or less, 0.05 mol / L or less, 0.04 mol / L or less, 0.03 mol / L or less, or 0.02 mol / L or less based on the volume of the process solution, specifically based on the volume of the fermentation process solution obtained in the first step.
[0063] When adipic acid is additionally added to the process solution in the second step, the adipic acid may be added before, after, or simultaneously with the conversion reaction, but is not limited thereto.
[0064] If adipic acid is additionally added in the second step, it is understood that the amount of adipic acid added throughout the process of the manufacturing method of the present application is the sum of the amount of diammonium adipate added to the medium in the first step and the amount of adipic acid added in the second step. In addition, if adipic acid is not additionally added to the process solution in the second step, it is understood that the amount of adipic acid added throughout the process of the manufacturing method of the present application is the same as the amount of diammonium adipate added to the medium in the first step.
[0065]
[0066] Specifically, the amount of adipic acid added in the manufacturing method of the present application may be added taking into account the amount of cadaverine in the process solution obtained after the second step. Specifically, the amount of adipic acid added in the manufacturing method of the present application may be a molar ratio of 0.85 to 1.05 relative to the amount of cadaverine in the process solution obtained after the second step.
[0067] More specifically, the amount of adipic acid added in the present application manufacturing method may be a molar ratio of 0.87 to 1.04, 0.87 to 1.03, 0.88 to 1.03, 0.88 to 1.02, 0.89 to 1.03, 0.89 to 1.02, 0.89 to 1.01, or 0.9 to 1.01 relative to the amount of cadaverine in the process solution after the second step.
[0068] For example, the amount of adipic acid added in the present application manufacturing method may be included in a molar ratio in a range consisting of one lower limit selected from 0.85, 0.86, 0.87, 0.88, 0.89, 0.9, 0.91, and 0.92 and / or one upper limit selected from 1.05, 1.04, 1.03, 1.02, and 1.01 relative to the amount of cadaverine in the process solution after the second step.
[0069] One technical significance of the present invention lies in the discovery that when adipic acid is added in a molar ratio within the above range in comparison with the amount of cadaverine calculated to be obtained after the second step in the manufacturing method of the present application, adipic acid does not precipitate as crystals together with cadaverine adipate, thereby enabling the production of high-purity and high-yield cadaverine adipate.
[0070] In addition, by adjusting the molar ratio of the cadaverine to be obtained and the adipic acid to be added, it is possible to maintain the purity of cadaverine adipate at 99% up to the third cycle during the circulation of the mother liquor, and cadaverine adipate can be obtained at a total yield of 45% or more, 47% or more, 57% or more, 59% or more, 64% or more, 68% or more, 69% or more, 70% or more, 71% or more, 72% or more, 73% or more, or 74% or more depending on the number of cycles of the mother liquor.
[0071]
[0072] In the second step, the conversion reaction of the lysine adipate into cadaverine adipate may be an enzymatic conversion reaction.
[0073] In one specific example, the lysine adipate may include both the lysine adipate obtained in the first step and the lysine adipate produced in the second step when adipic acid is additionally added in the second step.
[0074]
[0075] Specifically, the enzymatic conversion reaction of the second step can be performed using a protein having lysine decarboxylase activity or a microorganism expressing a protein having the activity.
[0076] As a specific example, a protein having lysine decarboxylase activity may be added to the fermentation process liquid of the first stage, or a starter culture of a microorganism expressing a protein having the activity may be added, but is not limited thereto.
[0077]
[0078] The term "decarboxylase" in this application refers to an enzyme that catalyzes the production of carbonic acid by removing a carboxyl group, which is an organic acid, and may also be named decarboxylase, decarboxylase, decarboxylase, decarboxylase, or carbonic acid decarboxylase.
[0079] The above protein is not particularly limited as long as it exhibits lysine decarboxylase activity, but may be, for example, PtLDC protein from Pseudomonas thermotolerans or CadA protein derived from Escherichia coli. However, the protein sequence may be obtained using GenBank, a known database, or expressed using the above microorganism, or a commercially available enzyme may be purchased and used, and is not limited thereto.
[0080] The microorganism expressing the above protein may be a microorganism transformed to express the protein. The transformed microorganism is not limited to a prokaryotic microorganism or a eukaryotic microorganism, as long as it is transformed to express a protein having decarboxylase activity. The microorganism transformed to express the protein having decarboxylase activity can convert lysine adipate in the process solution into cadaverine adipate by secreting the protein having the enzymatic activity into the starter culture solution.
[0081] Specific examples thereof may include strains of Escherichia, Erwinia, Serratia, Providencia, and coryneform microorganisms. The microorganism may specifically be a microorganism belonging to the genus Escherichia or the genus Corynebacterium, and more specifically, may be, but is not limited to, Escherichia coli or Corynebacterium glutamicum.
[0082]
[0083] The conversion reaction of the second step may be performed for 20 minutes to 3 hours, more specifically for 0.5 to 1.5 hours, and for example, for 1 hour, but is not limited thereto.
[0084] The conversion reaction of the second step may be performed at 30 to 60°C, more specifically at 40 to 50°C, and for example, at 45°C, but is not limited thereto.
[0085]
[0086] The conversion reaction of the second step may be performed at a pH of 7.5 to 9, more specifically at a pH of 7.8 to 8.7, and even more specifically at a pH of 8 to 8.5. In one embodiment of the second step, the pH may be adjusted to the above range by optionally adding adipic acid, and in another embodiment, the pH may be adjusted to the above range by adding CO2. When the pH range of the second step conversion reaction is adjusted to the above range, the conversion rate of lysine adipate to cadaverine adipate may be significantly increased.
[0087]
[0088] The method for producing cadaverine adipate of the present application may further include a recovery step of recovering the obtained cadaverine adipate after performing the second step.
[0089]
[0090] The above recovery may be by collecting cadaverine adipate using a suitable method known in the art.
[0091] For example, cadaverine adipate can be collected by various chromatographic methods such as centrifugation, filtration, concentration, crystallization, extraction, sonication, ultrafiltration, dialysis, molecular sieve chromatography (gel filtration), adsorption chromatography, ion exchange chromatography, affinity chromatography, HPLC, or a combination of these methods.
[0092]
[0093] In one specific embodiment of the present application, the recovery step may include one or more of a filtration step, a concentration step, and a crystallization step.
[0094]
[0095] The above filtration step refers to a step of removing impurities from the conversion solution containing cadaverine adipate obtained in the second step. As an example, the filtration may include removing cells in the cadaverine adipate process solution by performing membrane separation, etc., or performing activated carbon filtration, etc.
[0096] The above concentration step refers to a step of concentrating to increase the solid content ratio in the conversion solution, and may be performed after the filtration step. As an example, the concentration may be performed by reducing pressure concentration using a rotary evaporator.
[0097] Specifically, the above concentration step may be to concentrate so that the solid content becomes 65 to 85% (w / w), and more specifically, to concentrate so that the solid content becomes 70 to 85% (w / w), 72 to 83% (w / w), 65 to 80% (w / w), 65 to 75% (w / w), 75 to 85% (w / w), 70 to 80% (w / w), 72 to 78% (w / w), or 73 to 77% (w / w), and for example, to concentrate so that the solid content becomes 75% (w / w).
[0098] The above concentration step may be performed at 40 to 60°C, more specifically at 45 to 55°C, and for example, at 50°C, but is not limited thereto.
[0099]
[0100] The above crystallization step may be a cooling crystallization step, which means a step of cooling the conversion solution and precipitating it into crystals to obtain the final target product, cadaverine adipate crystals.
[0101] Specifically, the cooling may be cooling the conversion solution to 20 to 30°C, more specifically to 23 to 27°C, and for example to 25°C, but is not limited thereto.
[0102] Specifically, the cooling rate may be 5-20°C / hour, more specifically 5-15°C / hour, and for example, 10°C / hour, but is not limited thereto.
[0103]
[0104] In one embodiment, the recovery step may further include a stirring step for stirring the process solution. The stirring step may be performed simultaneously with the cooling crystallization step, during the cooling crystallization step, before the cooling crystallization step, or after the cooling crystallization step. This stirring step provides sufficient time for the process solution to be stirred, thereby facilitating crystal precipitation.
[0105]
[0106] In one embodiment, the recovery step may further include a mother liquor circulation step of recycling the mother liquor containing non-crystallized cadaverine adipate after the crystallization step to the feed liquor of the concentration step.
[0107] Specifically, in the mother liquor circulation step, the number of times the mother liquor is cycled may be 0 to 3 times, 1 to 3 times, 1 to 4 times, 1 to 5 times, 1 to 10 times, or more. In this case, a number of times the mother liquor is cycled being 0 means that the mother liquor circulation step is not performed.
[0108]
[0109] In the past, there was a problem that, in the step of crystallizing cadaverine adipate, a relatively large amount of cadaverine adipate, more than 50%, still remained in the mother liquor after crystallization, resulting in a low yield of less than 50%. In the present application, as a method for improving the yield of cadaverine adipate, the remaining mother liquor of cadaverine adipate is recycled as a feed liquid of the concentration step 1 to 3 times, 1 to 4 times, 1 to 5 times, 1 to 10 times or more, thereby increasing the total yield of cadaverine adipate to 69% or more, 70% or more, 71% or more, 72% or more, 73% or more, 74% or more, or more.
[0110]
[0111] In one embodiment, the recovery step may further include washing, separating, and drying the crystallized process solution.
[0112] In the above drying step, moisture contained in the crystals is removed through drying, and a high-purity cadaverine adipate can be commercialized. After drying, the cadaverine adipate crystals can be provided in powder form, but the formulation can be varied as needed.
[0113]
[0114] In one embodiment, the recovery step may further include a decolorization step. The decolorization may be performed using, but is not limited to, activated carbon, anion resin, or the like.
[0115]
[0116] Additionally, the method for producing cadaverine adipate of the present application may include an additional purification step. The purification may be performed using any suitable method known in the art. In one example, when the method for producing cadaverine adipate of the present application includes both a recovery step and a purification step, the recovery process and the purification process may be performed continuously or discontinuously, regardless of the order, or may be performed simultaneously or integrated into a single step, but is not limited thereto.
[0117]
[0118] The manufacturing method of the present application may be characterized by not including a separate process for removing adipate in the recovery step. In the case of the conventional cadaverine adipate production process, the adipate precipitates as crystals together during the crystallization process, lowering the purity. To prevent this, a separate process for removing the adipate prior to crystallization was required. However, the manufacturing method of the present application provides a technical advantage of producing high-purity cadaverine adipate without performing a separate adipate removal process.
[0119]
[0120] In one embodiment, the method of the present application may be characterized in that cadaverine adipate having a purity of 99% or higher can be obtained in the 0th to 3rd cycle of the mother liquor.
[0121] In one embodiment, based on three cycles of the above mother liquor, the cumulative total yield of cadaverine adipate may be 65% or more, and more specifically, 69%, 70%, 71%, 72%, 73%, 74% or more.
[0122]
[0123] The method of the present application allows for the production of high-purity cadaverine adipate without the decarboxylation and distillation processes required in the conventional liquid production of cadaverine.
[0124] The present application will be described in more detail below through examples. However, the following examples are merely preferred embodiments intended to illustrate the present application and are therefore not intended to limit the scope of the present application. Furthermore, technical details not described herein can be readily understood and implemented by those skilled in the technical field of the present application or similar fields.
[0125]
[0126] The above describes a process for manufacturing cadaverine adipate according to one embodiment of the present application. Below, the beneficial effects mentioned in the present application will be examined through experimental results of examples.
[0127]
[0128] Manufacturing Example 1-1. Fermentation process for producing lysine adipate
[0129] A Corynebacterium glutamicum strain (KCCM12154P, US Publication No. US 2021-0355514 A1) capable of producing lysine was cultured on solid surfaces and in flasks to obtain seed cultures. After seed culture in a fermenter, the main production fermentation was performed. The main production fermentation was performed by culturing the fermenter at 36°C for 30 hours at 900 rpm.
[0130] Instead of ammonium sulfate, diammonium adipate was supplied at a level of 72 to 117 g / L for each example, and as a result of fermentation, lysine adipate was obtained at a level of 116 to 190 g / L, and lysine was obtained at a level of 99 g / L. At this time, the molar ratio of adipic acid / lysine in the fermentation process liquid in the examples was at a level of 0.59 to 0.96, and in particular, in the cases of Examples 4 to 7, the molar ratio of adipic acid / lysine in the fermentation process liquid was adjusted to a range of 0.88 to 0.96.
[0131]
[0132] Manufacturing Example 1-2. Conversion reaction of lysine adipate to cadaverine adipate
[0133] For the conversion reaction, E. coli (US Patent Publication No. US 2018-0030430 A1) overexpressing the PtLDC enzyme, a lysine decarboxylase gene derived from Pseudomonas thermotolerans, using the pET-Deut1 vector was used.
[0134] The fermentation process liquid of lysine adipate prepared from the above Manufacturing Example 1-1 was supplied with the seed culture of the enzyme strain at a level of 10% based on the mass percentage to perform the conversion reaction. The conversion reaction temperature was maintained at 45 to 50°C and performed for about 1 hour. The pH was adjusted to 8.0 to 8.5, and for this purpose, in the cases of the following Examples 1 to 4, CO2 was added for neutralization, and in the cases of Examples 2 and 3, adipic acid was additionally added at a level of 0.02 to 0.03 mol / L (based on the volume of the fermentation process liquid of lysine adipate). Fig. 3 is a graph showing the results of the conversion reaction, and it was confirmed that the conversion rate was at the level of 97 to 98%. After the conversion reaction, cadaverine adipate was obtained at a level of 99 to 161 g / L (based on the volume of the fermentation process solution of lysine adipate), and cadaverine was obtained at a level of 68 g / L (based on the volume of the fermentation process solution of lysine adipate). In the case of Examples 5 to 7, adipic acid was additionally added at a level of 0.02 to 0.15 mol / L to prepare a process solution.
[0135]
[0136] Manufacturing Example 1-3. Subsequent processes after obtaining cadaverine adipate
[0137] After the conversion reaction according to Manufacturing Example 1-2, the following subsequent process was performed on the process solution containing cadaverine adipate to obtain cadaverine adipate in crystal form.
[0138] [Bacterial removal step]
[0139] The cells in the cadaverine adipate process solution were removed by performing membrane filtration with a pore size of 0.1 μm.
[0140] [Step to remove impurities using activated carbon]
[0141] Activated carbon was added to the filtrate from which the fungi had been removed at a level of 10% based on the weight of cadaverine adipate, heated to 60°C, stirred for 1 hour to decolorize, and then the activated carbon was filtered through a filter paper.
[0142] [Step of concentrating the cadaverine adipate process solution from which impurities have been removed]
[0143] The filtrate from which the activated carbon was removed was concentrated under reduced pressure at about 50°C and 120 Torr in a rotary evaporator until the solid content became 75% by weight.
[0144] [Step of cooling, crystallizing, and separating the cadaverine adipate concentrate and then drying it]
[0145] The above concentrate was cooled from 50°C to 25°C at a rate of 10°C / hr. The precipitated crystals were separated from the mother liquor using a centrifuge. The crystals were washed with water containing 10% of the weight of cadaverine adipate. The separated crystals were dried for one day, and their purity was measured by HPLC.
[0146] [Step of recycling the mother liquor to the crystallization stage]
[0147] The mother liquor separated above was recycled to the [step of concentrating the cadaverine adipate process solution from which impurities have been removed].
[0148]
[0149] Experimental Example 1. Confirmation of changes in cadaverine adipate purity and yield according to the molar ratio of adipate and cadaverine.
[0150] In Experimental Example 1, the method according to Manufacturing Examples 1-1 to 1-3 was used, and it was confirmed how the purity and yield of cadaverine adipate changed depending on the molar ratio of adipic acid added throughout the entire process and cadaverine in the process solution after the second step.
[0151]
[0152] Example 1: When the molar ratio of added adipic acid / cadaverine in the process solution after the second step is 0.6
[0153] 1,000 ml of a cadaverine adipate conversion solution having an adipate / cadaverine molar ratio of 0.6 was passed through a membrane with a pore size of 0.1 μm to remove bacterial cells. The cadaverine adipate conversion solution having an adipate / cadaverine molar ratio of 0.6 was produced by controlling the total moles of diammonium adipate added in the fermentation process for producing lysine adipate and adipic acid added in the cadaverine adipate conversion reaction so that the moles of the converted cadaverine were 0.6 (see Equation 1 below).
[0154] [Formula 1]
[0155]
[0156]
[0157] The filtrate from which the mycelia were removed was decolorized using activated carbon and filtered through filter paper, and then concentrated under reduced pressure to a solids content of 75%. The concentrate was cooled from 60°C to 25°C to crystallize. The crystals and mother liquor were separated by centrifugation, and the separated crystals were dried for one day and their purity was measured by HPLC. The mother liquor containing the remaining adipate was recycled to the cadaverine adipate feed solution having an adipic acid / cadaverine molar ratio of 0.6, and then the crystallization step was performed again. The recycling of the mother liquor was performed sequentially.
[0158]
[0159] Example 2: When the molar ratio of added adipic acid / cadaverine in the process solution after the second step is 0.71
[0160] A cadaverine adipate conversion solution having an adipic acid / cadaverine molar ratio of 0.71 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 1.
[0161]
[0162] Example 3: When the molar ratio of added adipic acid / cadaverine in the process solution after the second step is 0.8
[0163] A cadaverine adipate conversion solution having an adipic acid / cadaverine molar ratio of 0.8 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 1.
[0164]
[0165] Example 4: When the molar ratio of added adipic acid / cadaverine in the process solution after the second step is 0.9
[0166] A cadaverine adipate conversion solution having an adipic acid / cadaverine molar ratio of 0.9 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 1.
[0167]
[0168] Example 5: When the molar ratio of added adipic acid / cadaverine in the process solution after the second step is 1.01
[0169] A cadaverine adipate conversion solution having an adipic acid / cadaverine molar ratio of 1.01 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 1.
[0170] For the above examples 4 and 5, the molar ratio of adipic acid / lysine in the lysine fermentation step was adjusted to 0.85-0.98.
[0171]
[0172] Example 6: When the molar ratio of added adipic acid / cadaverine in the process solution after the second step is 1.1
[0173] A cadaverine adipate conversion solution having an adipic acid / cadaverine molar ratio of 1.1 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 1.
[0174]
[0175] Example 7: When the molar ratio of added adipic acid / cadaverine in the process solution after the second step is 1.2
[0176] A cadaverine adipate conversion solution having an adipic acid / cadaverine molar ratio of 1.2 was supplied, and the mother liquor was sequentially recycled and a purification process was performed in the same manner as in Example 1.
[0177]
[0178] The physical property measurements for the process solutions and cadaverine adipate salts manufactured according to the above-described Examples 1 to 7 are as shown in the following Tables 1 to 4.
[0179]
[0180] Table 1 shows the process solution that did not circulate the mother liquor.
[0181] No mother liquor circulation Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Example 7 Adipic acid / cadaverine molar ratio 0.6 0.7 10.8 0.9 1.0 11.11.2 Crystallization feed New feed ml 1000 1000 1000 1000 1000 1000 1000 Amount of cadaverine in crystallization solution, g 285 285 285 285 285 285 Amount of cadaverine in crystals produced, g No crystals produced 107 118 127 134 125 116 Amount of cadaverine in mother liquor, g - 1 7 8 16 7 15 8 15 116 0 169 Result Purity, % - 98% 98% 98% 99% 97% 92% Yield, %-38%41%45%47%44%41%Total yield, %-38%41%45%47%44%41%
[0182] Table 2 shows the process solution that has been circulated once.
[0183] Mother liquor circulation 1 timeExample 1Example 2Example 3Example 4Example 5Example 6Example 7Adipic acid / cadaverine molar ratio0.60.710.80.91.011.11.2Crystallization feed solutionNew feed solution ml100010001000100010001000Amount of cadaverine in crystallization solution, g462451443436445453Amount of cadaverine in produced crystals, g174187197204195184Amount of cadaverine in mother liquor, g289264246231250269Result Purity, %98%99%99%99%93%84%Yield, %38%41%45%47%44%41%Total yield, %49%54%57%59%56%53%
[0184] Table 3 shows the process solution that was cycled twice.
[0185] Mother liquor circulation 2 timesExample 1Example 2Example 3Example 4Example 5Example 6Example 7Adipic acid / cadaverine molar ratio0.60.710.80.91.011.11.2Crystallization feed New feed ml-10001000100010001000-Amount of cadaverine in crystallization solution, g-573549530516534-Amount of cadaverine in produced crystals, g-Crystals not produced206226242221-Amount of cadaverine in mother liquor, g-342305274313-Results Purity, %--98%98%99%86%-Yield, %--38%43%47%41%-Total yield, %--60%64%68%63%-
[0186] Table 4 shows the process solution after circulating the mother liquor three times.
[0187] Mother liquor circulation 3 timesExample 1Example 2Example 3Example 4Example 5Example 6Example 7Adipic acid / cadaverine molar ratio0.60.710.80.91.011.11.2Crystallization feed New feed ml--100010001000--Amount of cadaverine in crystallization solution, g--285675627--Amount of cadaverine in crystals formed, g--No crystals formed265294--Amount of cadaverine in mother liquor, g--- 409333--Results Purity, %---99%99%--Yield, %---39%47%--Total yield, %---69%74%--
[0188] By summarizing the experimental results according to Tables 1 to 4 above, it was confirmed that the presently applied manufacturing method, which includes a large amount of diammonium adipate in the first step at 81-100 mol% of the total supplied adipic acid, enables the production of cadaverine adipate with an overall improved crystallization rate, high purity, and high yield.
[0189]
[0190] More specifically, in the case of Example 1, even when the crystallization process was performed, no crystals were precipitated. This is because the molar ratio of adipic acid was low, which was not sufficient for crystals of cadaverine adipate to precipitate.
[0191] In Example 2, crystals were formed up to the first cycle of mother liquor circulation, but no crystals were formed in the second cycle. This is because the molar ratio of adipic acid in the crystallization feed solution was reduced after the first cycle of mother liquor circulation, making it insufficient for crystals of cadaverine adipate to be formed.
[0192] In Example 3, crystals were precipitated up to the second cycle of mother liquor circulation, but no crystals were formed in the third cycle. This is because the sequentially circulated mother liquor lowered the molar ratio of adipic acid to the crystallization feed liquid, and thus the concentration of adipate was not sufficient to precipitate crystals of cadaverine adipate.
[0193] Example 4 obtained 99% high-purity cadaverine adipate up to the third cycle of mother liquor circulation, and was able to achieve a high total yield of approximately 70%.
[0194] Example 5 obtained 99% high-purity cadaverine adipate up to the third cycle of mother liquor circulation, and also achieved a high yield of approximately 74% in total yield.
[0195] In Example 6, crystals were precipitated up to the second cycle of mother liquor circulation, but the purity of the crystals dropped slightly to 86%. This is because adipic acid accumulated in the crystallization feed liquid as the mother liquor was sequentially circulated, causing adipic acid to precipitate as an impurity.
[0196] In Example 7, the purity of the crystals dropped slightly to 84% in the first cycle of mother liquor circulation. This is because adipic acid accumulated in the crystallization feed liquid as the mother liquor was sequentially circulated, causing adipic acid to precipitate as an impurity.
[0197]
[0198] In this way, it was found that a method for producing high-purity cadaverine adipate can be provided depending on the molar ratio of adipic acid added throughout the entire process relative to the amount of cadaverine in the process solution after the second step. In particular, it was confirmed that when the amount of adipic acid added was adjusted to a molar ratio of about 0.9 to 1.01 relative to the amount of cadaverine in the process solution after the second step, an excellent total yield of 69% or more could be achieved while maintaining a purity of 99% of cadaverine adipate even after three or more cycles of mother liquor circulation.
[0199]
[0200] From the above description, those skilled in the art will understand that the present application can be implemented in other specific forms without altering its technical concept or essential characteristics. In this regard, it should be understood that the embodiments described above are illustrative in all respects and not restrictive. The scope of this application should be interpreted to include all changes or modifications derived from the meaning and scope of the following claims and their equivalents, rather than the detailed description above.
Claims
1. A first step of obtaining lysine adipate by culturing an L-lysine producing microorganism in a medium to which adipic acid is added in the form of diammonium adipate; and A method for producing cadaverine adipate, comprising a second step of converting lysine adipate into cadaverine adipate, The amount of adipic acid added is included in a molar ratio of 0.85 to 1.05 relative to the amount of cadaverine in the process solution after the second step. Method for producing cadaverine adipate.
2. In paragraph 1, A method for producing cadaverine adipate, wherein the diammonium adipate of the first step is comprised of 81 mol% or more of the total supplied adipic acid.
3. In paragraph 1, A method for producing cadaverine adipate, wherein the diammonium adipate of the first step is included so that the molar ratio (diammonium adipate / lysine) with the lysine to be produced is 0.85 to 0.
98.
4. A method for producing cadaverine adipate in the first paragraph, wherein the conversion reaction of the second step is performed at a pH of 8.0 to 8.
5.
5. In paragraph 1, A method for producing cadaverine adipate, wherein the amount of adipic acid added is a molar ratio of 0.88 to 1.02 relative to the amount of cadaverine in the process solution after the second step.
6. In paragraph 1, A method for producing cadaverine adipate, further comprising a recovery step of recovering cadaverine adipate after performing the second step.
7. In paragraph 6, A method for producing cadaverine adipate, wherein the recovery step comprises at least one step selected from the group consisting of a filtration step, a concentration step, and a cooling crystallization step.
8. In paragraph 7, the recovery step A method for producing cadaverine adipate, further comprising a mother liquor circulation step of recycling the mother liquor containing non-crystallized cadaverine adipate after the cooling crystallization step as a feed liquid of a concentration step.
9. A method for producing cadaverine adipate in the 7th paragraph, wherein the concentration step is to concentrate so that the solid content becomes 70 to 80% (w / w).
10. In paragraph 1, A method for producing cadaverine adipate, wherein in the second step, converting lysine adipate into cadaverine adipate is performed using a protein having lysine decarboxylase activity or a microorganism expressing a protein having the activity.
11. In paragraph 1, A method for producing cadaverine adipate, wherein the above L-lysine producing microorganism is Corynebacterium glutamicum.
12. A method for producing cadaverine adipate, characterized in that the recovery step of claim 1 does not include a separate process for removing adipate from the process solution.
13. In paragraph 8, A method for producing cadaverine adipate, wherein cadaverine adipate having a purity of 99% or higher can be obtained in the 0th to 3rd cycle of the above-mentioned mother liquor.
Citation Information
Patent Citations
Novel lysine decarboxylase, and method for producing cadaverine by using same
US20180030430A1
Modified polypeptide with attenuated activity of citrate synthase and method for producing l-amino acid using the same
US20210355514A1
Method for producing cadaverine dicarboxylate and its use for the production of nylon
EP1482055A1
Method for producing aqueous cadaverine salt solution, cadaverine salt solution, cadaverine salt, polyamide resin, and molding
JP2008189661A
Process for the production of cadaverine
KR1020090005099A
